Val Dokuzovic

Title: Val Dokuzovic: Innovator in Antitussive Drug Delivery

Introduction

Val Dokuzovic is a notable inventor based in Mississauga, Canada. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antitussive drugs. His innovative approach has led to the creation of a unique drug delivery system that enhances the efficacy of cough medications.

Latest Patents

Val Dokuzovic holds a patent for "Antitussive drugs delivered by ion exchange resins." This invention involves a mixture of coated and non-coated sulfonic acid cation exchange resins, specifically Amberlite IR69, which are cross-linked with approximately 8% divinyl benzene. The patent details a method where dextromethorphan is loaded onto these resins, with about 30% of the drug/resin complexes being coated with a mixture of ethyl cellulose and water-dispersible polymers. The coating level is around 50% w/w drug, and the drug/resin complexes are loaded to about 45% by weight. The ratio of coated to uncoated complexes is approximately 55/45, with particle sizes ranging from 20 to 300 microns for coated and 20 to 250 microns for uncoated complexes.

Career Highlights

Val Dokuzovic has had a distinguished career, working at Warner-Lambert Company, where he has been able to apply his expertise in pharmaceutical innovations. His work has not only contributed to the advancement of drug delivery systems but has also positioned him as a key figure in the industry.

Collaborations

Throughout his career, Val has collaborated with notable colleagues, including Betty P. Wen and Michael P. Ramsay. These collaborations have further enriched his research and development efforts, leading to innovative solutions in the pharmaceutical sector.

Conclusion

Val Dokuzovic's contributions to the field of antitussive drug delivery exemplify the impact of innovative thinking in pharmaceuticals. His patent and career achievements highlight the importance of research and collaboration in advancing medical science.